Company Filing History:
Years Active: 2024
Title: Nathan Thomas Ross: Innovator in Selective Protein Degradation
Introduction
Nathan Thomas Ross is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of biochemistry. He holds a patent that focuses on innovative methods for selective protein degradation, which has implications for various therapeutic applications.
Latest Patents
Ross's most notable patent is titled "Compositions and methods for selective protein degradation." This invention provides compositions that include a fusion polypeptide and methods for creating a fusion polypeptide that incorporates a COF1/CRBN-binding polypeptide, COF2/CRBN-binding polypeptide, or COF3/CRBN-binding polypeptide along with a heterologous polypeptide of interest. This advancement is crucial for researchers looking to manipulate protein levels in biological systems.
Career Highlights
Nathan Thomas Ross is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore and develop groundbreaking solutions in the realm of drug discovery and development. His expertise in protein degradation is paving the way for new therapeutic strategies.
Collaborations
Ross collaborates with esteemed colleagues, including James Bradner and Andrei Alexandrovich Golosov. These partnerships enhance the research environment and foster innovation within the field.
Conclusion
Nathan Thomas Ross is a key figure in the advancement of selective protein degradation technologies. His patent and work at Novartis AG highlight his commitment to innovation in biochemistry. His contributions are expected to have a lasting impact on therapeutic development.